Tectonic Therapeutic, Inc. financial data

Symbol
TECX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 210, Watertown, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
AvroBio, Inc. (to 6/18/2024), AVROBIO, Inc. (to 6/18/2024)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 538 % -31.2%
Debt-to-equity 96.6 %
Return On Equity 43.1 % -88.6%
Return On Assets 8.4 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 14.7M shares -66.9%
Common Stock, Shares, Outstanding 14.7M shares -66.7%
Entity Public Float 36.6M USD -99.9%
Common Stock, Value, Issued 2K USD -50%
Weighted Average Number of Shares Outstanding, Basic 2.92M shares +138%
Weighted Average Number of Shares Outstanding, Diluted 2.92M shares +138%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 29.4M USD -51.2%
General and Administrative Expense 25.8M USD +7.86%
Costs and Expenses 1.78M USD -3.31%
Operating Income (Loss) 26.7M USD -7.43%
Nonoperating Income (Expense) 1.79M USD +163%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 9.17M USD -21.2%
Earnings Per Share, Basic 4.86 USD/shares +49%
Earnings Per Share, Diluted 4.86 USD/shares +49%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 185M USD +1140%
Other Assets, Current 626K USD -25.9%
Assets, Current 187M USD +45.4%
Property, Plant and Equipment, Net 2.64M USD +15.5%
Operating Lease, Right-of-Use Asset 1.21M USD -46.7%
Other Assets, Noncurrent 13K USD -67.5%
Assets 194M USD +44.9%
Accounts Payable, Current 4.09M USD +282%
Employee-related Liabilities, Current 2.76M USD -25.4%
Accrued Liabilities, Current 20M USD +140%
Liabilities, Current 26M USD +123%
Deferred Income Tax Liabilities, Net 0 USD
Operating Lease, Liability, Noncurrent 905K USD +575%
Liabilities 27.5M USD +133%
Accumulated Other Comprehensive Income (Loss), Net of Tax -61K USD
Retained Earnings (Accumulated Deficit) -118M USD +73.5%
Stockholders' Equity Attributable to Parent 166M USD
Liabilities and Equity 194M USD +44.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -7.57M USD +62.7%
Net Cash Provided by (Used in) Financing Activities 55K USD -61.3%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 14.7M shares -66.7%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.54M USD +62.7%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 186M USD +1097%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 119M USD -4.84%
Deferred Tax Assets, Gross 119M USD -4.99%
Operating Lease, Liability 2.33M USD -2.14%
Depreciation 264K USD +7.32%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -119M USD +3.63%
Lessee, Operating Lease, Liability, to be Paid 2.48M USD
Property, Plant and Equipment, Gross 5.02M USD -25.1%
Operating Lease, Liability, Current 1.43M USD -36.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 132K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.58M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 148K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 0 USD
Deferred Tax Assets, Operating Loss Carryforwards 80.2M USD -12.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Additional Paid in Capital 285M USD
Preferred Stock, Shares Outstanding 0 shares
Operating Leases, Future Minimum Payments, Due in Two Years 69K USD
Depreciation, Depletion and Amortization 0 USD -100%
Operating Leases, Future Minimum Payments Due, Next Twelve Months 1.03M USD
Deferred Tax Assets, Net of Valuation Allowance 118K USD -63.1%
Share-based Payment Arrangement, Expense 5.37M USD -30.5%
Operating Leases, Future Minimum Payments, Due in Three Years 0 USD
Operating Leases, Future Minimum Payments Due 1.81M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares